Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Dyssynchronous secretory endometrial glands often show sporadically acquired progesterone nonresponsiveness.

Howitt BE, Monte NM, Elvin J, Mutter GL.

Int J Gynecol Pathol. 2015 May;34(3):239-44. doi: 10.1097/PGP.0000000000000157.

PMID:
25844547
2.

Biomarker resolution of uterine smooth muscle tumor necrosis as benign vs malignant.

Yang EJ, Mutter GL.

Mod Pathol. 2015 Feb 20. doi: 10.1038/modpathol.2015.35. [Epub ahead of print]

PMID:
25698060
3.

ARID1A is a useful marker of malignancy in peritoneal washings for endometrial carcinoma.

Nagymanyoki Z, Mutter GL, Hornick JL, Cibas ES.

Cancer Cytopathol. 2015 Apr;123(4):253-7. doi: 10.1002/cncy.21514. Epub 2014 Dec 29.

PMID:
25557364
4.

Selection of functional human sperm with higher DNA integrity and fewer reactive oxygen species.

Asghar W, Velasco V, Kingsley JL, Shoukat MS, Shafiee H, Anchan RM, Mutter GL, Tüzel E, Demirci U.

Adv Healthc Mater. 2014 Oct;3(10):1671-9. doi: 10.1002/adhm.201400058. Epub 2014 Apr 17.

PMID:
24753434
5.

Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.

Mutter GL, Monte NM, Neuberg D, Ferenczy A, Eng C.

Cancer Res. 2014 May 15;74(10):2796-802. doi: 10.1158/0008-5472.CAN-14-0108. Epub 2014 Mar 24. Erratum in: Cancer Res. 2014 Jul 1;74(13):3644.

PMID:
24662919
6.

Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms.

Parra-Herran CE, Monte NM, Mutter GL.

Mod Pathol. 2013 Jun;26(6):868-73. doi: 10.1038/modpathol.2012.231. Epub 2013 Jan 18.

7.

Management of endometrial precancers.

Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL; Society of Gynecologic Oncology Clinical Practice Committee.

Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: http://10.1097/AOG.0b013e31826bb121. Review.

8.

Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia.

Quick CM, Laury AR, Monte NM, Mutter GL.

Am J Clin Pathol. 2012 Nov;138(5):678-84. doi: 10.1309/AJCP8OMLT7KDWLMF.

9.

Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.

Usubutun A, Mutter GL, Saglam A, Dolgun A, Ozkan EA, Ince T, Akyol A, Bulbul HD, Calay Z, Eren F, Gumurdulu D, Haberal AN, Ilvan S, Karaveli S, Koyuncuoglu M, Muezzinoglu B, Muftuoglu KH, Ozdemir N, Ozen O, Baykara S, Pestereli E, Ulukus EC, Zekioglu O.

Mod Pathol. 2012 Jun;25(6):877-84. doi: 10.1038/modpathol.2011.220. Epub 2012 Feb 3.

10.

Endometrial intraepithelial neoplasia: clinical correlates and outcomes.

Semere LG, Ko E, Johnson NR, Vitonis AF, Phang LJ, Cramer DW, Mutter GL.

Obstet Gynecol. 2011 Jul;118(1):21-8. doi: 10.1097/AOG.0b013e31821d78af.

11.

Endometrial intraepithelial neoplasia.

Jarboe EA, Mutter GL.

Semin Diagn Pathol. 2010 Nov;27(4):215-25. Review.

PMID:
21309257
12.

Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium.

Huang EC, Mutter GL, Crum CP, Nucci MR.

Mod Pathol. 2010 Nov;23(11):1486-91. doi: 10.1038/modpathol.2010.140. Epub 2010 Jul 30.

13.

Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL.

Cancer Res. 2010 Aug 1;70(15):6225-32. doi: 10.1158/0008-5472.CAN-10-0149. Epub 2010 Jul 14.

14.

Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.

Chen EY, Mehra K, Mehrad M, Ning G, Miron A, Mutter GL, Monte N, Quade BJ, McKeon FD, Yassin Y, Xian W, Crum CP.

J Pathol. 2010 Sep;222(1):110-6. doi: 10.1002/path.2739.

15.

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

Roh MH, Yassin Y, Miron A, Mehra KK, Mehrad M, Monte NM, Mutter GL, Nucci MR, Ning G, Mckeon FD, Hirsch MS, Wa X, Crum CP.

Mod Pathol. 2010 Oct;23(10):1316-24. doi: 10.1038/modpathol.2010.119. Epub 2010 Jun 18.

16.

Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.

Jarboe EA, Miron A, Carlson JW, Hirsch MS, Kindelberger D, Mutter GL, Crum CP, Nucci MR.

Int J Gynecol Pathol. 2009 Jul;28(4):308-15. doi: 10.1097/PGP.0b013e3181934390.

PMID:
19483636
17.

Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.

Lin MC, Burkholder KA, Viswanathan AN, Neuberg D, Mutter GL.

Cancer. 2009 May 15;115(10):2111-8. doi: 10.1002/cncr.24218.

18.

Squamous morules are functionally inert elements of premalignant endometrial neoplasia.

Lin MC, Lomo L, Baak JP, Eng C, Ince TA, Crum CP, Mutter GL.

Mod Pathol. 2009 Feb;22(2):167-74. doi: 10.1038/modpathol.2008.146. Epub 2008 Sep 19.

19.

Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.

Jarboe EA, Pizer ES, Miron A, Monte N, Mutter GL, Crum CP.

Mod Pathol. 2009 Mar;22(3):345-50. doi: 10.1038/modpathol.2008.197. Epub 2009 Jan 16.

20.

Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator.

Ioffe OB, Zaino RJ, Mutter GL.

Mod Pathol. 2009 Mar;22(3):450-9. doi: 10.1038/modpathol.2008.204. Epub 2009 Jan 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk